STAT-3 activity in chemically-induced hepatocellular carcinoma - PubMed (original) (raw)
STAT-3 activity in chemically-induced hepatocellular carcinoma
A Sánchez et al. Eur J Cancer. 2003 Sep.
Abstract
The signal transducer and activator of transcription (STAT)-3 regulates basic biological processes and it has been reported to be constitutively active in different types of malignant tumours. STAT-3 is active during the regenerative growth of the liver, but there are hardly any data about its presence in liver tumours. We investigated and found a high activity of STAT-3 using an electrophoretic mobility shift assay (EMSA) in chemically-induced rat hepatocellular carcinomas (HCCs). Dexamethasone treatment downregulated both STAT-3 activity and cell proliferation in the tumours. Therefore, the activity of the STAT-3 signal transduction pathway seems to be required for the growth of HCCs and could be a potential new target for therapeutic trials of this tumour type.
Similar articles
- STAT3 induces anti-hepatitis C viral activity in liver cells.
Zhu H, Shang X, Terada N, Liu C. Zhu H, et al. Biochem Biophys Res Commun. 2004 Nov 12;324(2):518-28. doi: 10.1016/j.bbrc.2004.09.081. Biochem Biophys Res Commun. 2004. PMID: 15474458 - Lipoxin A4 inhibits TNF-alpha-induced production of interleukins and proliferation of rat mesangial cells.
Wu SH, Lu C, Dong L, Zhou GP, He ZG, Chen ZQ. Wu SH, et al. Kidney Int. 2005 Jul;68(1):35-46. doi: 10.1111/j.1523-1755.2005.00379.x. Kidney Int. 2005. PMID: 15954894 - Different patterns of regulation of Tyr-phosphorylated STAT1 and STAT3 in human hepatoma Hep3B cells by the phosphatase inhibitor orthovanadate.
Sehgal PB, Kumar V, Guo G, Murray WC. Sehgal PB, et al. Arch Biochem Biophys. 2003 Apr 15;412(2):242-50. doi: 10.1016/s0003-9861(03)00050-x. Arch Biochem Biophys. 2003. PMID: 12667488 - Potential role of signal transducer and activator of transcription (STAT)3 signaling pathway in inflammation, survival, proliferation and invasion of hepatocellular carcinoma.
Subramaniam A, Shanmugam MK, Perumal E, Li F, Nachiyappan A, Dai X, Swamy SN, Ahn KS, Kumar AP, Tan BK, Hui KM, Sethi G. Subramaniam A, et al. Biochim Biophys Acta. 2013 Jan;1835(1):46-60. doi: 10.1016/j.bbcan.2012.10.002. Epub 2012 Oct 26. Biochim Biophys Acta. 2013. PMID: 23103770 Review.
Cited by
- Role of interleukin 6 in liver cell regeneration after hemi-hepatectomy, correlation with liver enzymes and flow cytometric study.
Al-Ghamdi TH, Atta IS, El-Refaei M. Al-Ghamdi TH, et al. Clin Exp Hepatol. 2020 Feb;6(1):42-48. doi: 10.5114/ceh.2020.93055. Epub 2020 Feb 17. Clin Exp Hepatol. 2020. PMID: 32166123 Free PMC article. - Modulation of the IL-6-Signaling Pathway in Liver Cells by miRNAs Targeting gp130, JAK1, and/or STAT3.
Servais FA, Kirchmeyer M, Hamdorf M, Minoungou NWE, Rose-John S, Kreis S, Haan C, Behrmann I. Servais FA, et al. Mol Ther Nucleic Acids. 2019 Jun 7;16:419-433. doi: 10.1016/j.omtn.2019.03.007. Epub 2019 Apr 2. Mol Ther Nucleic Acids. 2019. PMID: 31026677 Free PMC article. - Downregulated Expression of PTPN9 Contributes to Human Hepatocellular Carcinoma Growth and Progression.
Hu B, Yan X, Liu F, Zhu C, Zhou H, Chen Y, Liu J, Gu X, Ni R, Zhang T. Hu B, et al. Pathol Oncol Res. 2016 Jul;22(3):555-65. doi: 10.1007/s12253-015-0038-1. Epub 2015 Dec 29. Pathol Oncol Res. 2016. PMID: 26715439 - c-Jun mediates hepatitis C virus hepatocarcinogenesis through signal transducer and activator of transcription 3 and nitric oxide-dependent impairment of oxidative DNA repair.
Machida K, Tsukamoto H, Liu JC, Han YP, Govindarajan S, Lai MM, Akira S, Ou JH. Machida K, et al. Hepatology. 2010 Aug;52(2):480-92. doi: 10.1002/hep.23697. Hepatology. 2010. PMID: 20683948 Free PMC article. - Cloning and characterization of the human glutathione synthetase 5'-flanking region.
Lee TD, Yang H, Whang J, Lu SC. Lee TD, et al. Biochem J. 2005 Sep 1;390(Pt 2):521-8. doi: 10.1042/BJ20050439. Biochem J. 2005. PMID: 15890065 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous